Listed

Biomea Fusion, Inc.

BMEANasdaqCIK 1840439HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last eight fiscal years. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$83.5m, FY2025
Net income−$61.8m, FY2025
Line itemUnitFY2019-12-31FY2020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Research and development$m1.1Research and development, period not labelled, twelve months to 2019-12-31$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2022-02-28, accession 0001564590-22-007624.Report this figure3.7Research and development, period not labelled, twelve months to 2020-12-31$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure28.0Research and development, FY2021, twelve months to 2021-12-31$28.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure62.7Research and development, FY2022, twelve months to 2022-12-31$62.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure103Research and development, FY2023, twelve months to 2023-12-31$102.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure118Research and development, FY2024, twelve months to 2024-12-31$118.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure62.0Research and development, FY2025, twelve months to 2025-12-31$62.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure
Operating income$m(1.2)Operating income, period not labelled, twelve months to 2019-12-31−$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2022-02-28, accession 0001564590-22-007624.Report this figure(5.3)Operating income, period not labelled, twelve months to 2020-12-31−$5.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure(41.7)Operating income, FY2021, twelve months to 2021-12-31−$41.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure(83.6)Operating income, FY2022, twelve months to 2022-12-31−$83.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(126)Operating income, FY2023, twelve months to 2023-12-31−$126.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(144)Operating income, FY2024, twelve months to 2024-12-31−$144.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(83.5)Operating income, FY2025, twelve months to 2025-12-31−$83.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure
Income tax$mnot reported0.0Income tax, period not labelled, twelve months to 2020-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure0.0Income tax, FY2021, twelve months to 2021-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure0.0Income tax, FY2022, twelve months to 2022-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure0.0Income tax, FY2023, twelve months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure0.0Income tax, FY2024, twelve months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure0.0Income tax, FY2025, twelve months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure
Net income$m(1.2)Net income, period not labelled, twelve months to 2019-12-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2022-02-28, accession 0001564590-22-007624.Report this figure(5.3)Net income, period not labelled, twelve months to 2020-12-31−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure(41.6)Net income, FY2021, twelve months to 2021-12-31−$41.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure(81.8)Net income, FY2022, twelve months to 2022-12-31−$81.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(117)Net income, FY2023, twelve months to 2023-12-31−$117.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(138)Net income, FY2024, twelve months to 2024-12-31−$138.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(61.8)Net income, FY2025, twelve months to 2025-12-31−$61.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure
Diluted EPS$ per share(0.20)Diluted EPS, period not labelled, twelve months to 2019-12-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasicAndDiluted. 10-K filed 2022-02-28, accession 0001564590-22-007624.Report this figure(0.51)Diluted EPS, period not labelled, twelve months to 2020-12-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure(1.74)Diluted EPS, FY2021, twelve months to 2021-12-31−$1.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure(2.80)Diluted EPS, FY2022, twelve months to 2022-12-31−$2.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(3.44)Diluted EPS, FY2023, twelve months to 2023-12-31−$3.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(3.83)Diluted EPS, FY2024, twelve months to 2024-12-31−$3.83 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(1.18)Diluted EPS, FY2025, twelve months to 2025-12-31−$1.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure
Basic EPS$ per sharenot reported(0.51)Basic EPS, period not labelled, twelve months to 2020-12-31−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure(1.74)Basic EPS, FY2021, twelve months to 2021-12-31−$1.74 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure(2.80)Basic EPS, FY2022, twelve months to 2022-12-31−$2.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(3.44)Basic EPS, FY2023, twelve months to 2023-12-31−$3.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(3.83)Basic EPS, FY2024, twelve months to 2024-12-31−$3.83 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(1.18)Basic EPS, FY2025, twelve months to 2025-12-31−$1.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure

Balance sheet

Cash and equivalents$55.8m, FY2025
Shareholders' equity$29.6m, FY2025
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$m146Cash and equivalents, FY2021, at 2021-12-31$145.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure112Cash and equivalents, FY2022, at 2022-12-31$111.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure177Cash and equivalents, FY2023, at 2023-12-31$176.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure58.3Cash and equivalents, FY2024, at 2024-12-31$58.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure55.8Cash and equivalents, FY2025, at 2025-12-31$55.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Current assets$m177Current assets, FY2021, at 2021-12-31$176.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure118Current assets, FY2022, at 2022-12-31$117.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure179Current assets, FY2023, at 2023-12-31$179.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure68.3Current assets, FY2024, at 2024-12-31$68.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure58.1Current assets, FY2025, at 2025-12-31$58.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Total assets$m186Total assets, FY2021, at 2021-12-31$185.7m. XBRL concept us-gaap:Assets. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure129Total assets, FY2022, at 2022-12-31$129.3m. XBRL concept us-gaap:Assets. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure200Total assets, FY2023, at 2023-12-31$199.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure79.9Total assets, FY2024, at 2024-12-31$79.9m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure58.6Total assets, FY2025, at 2025-12-31$58.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Current liabilities$m4.6Current liabilities, FY2021, at 2021-12-31$4.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure19.1Current liabilities, FY2022, at 2022-12-31$19.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure22.9Current liabilities, FY2023, at 2023-12-31$22.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure21.7Current liabilities, FY2024, at 2024-12-31$21.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure11.1Current liabilities, FY2025, at 2025-12-31$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Total liabilities$m6.9Total liabilities, FY2021, at 2021-12-31$6.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure20.8Total liabilities, FY2022, at 2022-12-31$20.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure30.7Total liabilities, FY2023, at 2023-12-31$30.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure28.4Total liabilities, FY2024, at 2024-12-31$28.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure29.0Total liabilities, FY2025, at 2025-12-31$29.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure
Shareholders' equity$m179Shareholders' equity, FY2021, at 2021-12-31$178.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure109Shareholders' equity, FY2022, at 2022-12-31$108.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure169Shareholders' equity, FY2023, at 2023-12-31$169.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure51.6Shareholders' equity, FY2024, at 2024-12-31$51.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure29.6Shareholders' equity, FY2025, at 2025-12-31$29.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure

Cash flow

Operating cash flow−$70.4m, FY2025
Capital expenditure$362.0k, FY2024
Line itemUnitFY2019-12-31FY2020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Operating cash flow$m(1.3)Operating cash flow, period not labelled, twelve months to 2019-12-31−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2022-02-28, accession 0001564590-22-007624.Report this figure(4.5)Operating cash flow, period not labelled, twelve months to 2020-12-31−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure(35.4)Operating cash flow, FY2021, twelve months to 2021-12-31−$35.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure(62.4)Operating cash flow, FY2022, twelve months to 2022-12-31−$62.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure(96.6)Operating cash flow, FY2023, twelve months to 2023-12-31−$96.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(120)Operating cash flow, FY2024, twelve months to 2024-12-31−$119.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure(70.4)Operating cash flow, FY2025, twelve months to 2025-12-31−$70.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure
Capital expenditure$mnot reported0.1Capital expenditure, period not labelled, twelve months to 2020-12-31$51.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure3.2Capital expenditure, FY2021, twelve months to 2021-12-31$3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure1.0Capital expenditure, FY2022, twelve months to 2022-12-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure3.4Capital expenditure, FY2023, twelve months to 2023-12-31$3.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure0.4Capital expenditure, FY2024, twelve months to 2024-12-31$362.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figurenot reported

Shares

Diluted shares (weighted)52.23m, FY2025
Line itemUnitFY2020-12-31FY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Diluted shares (weighted)m shares10.5Diluted shares (weighted), period not labelled, twelve months to 2020-12-3110,532,942 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2023-03-28, accession 0000950170-23-010312.Report this figure23.9Diluted shares (weighted), FY2021, twelve months to 2021-12-3123,858,552 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2024-03-28, accession 0000950170-24-038026.Report this figure29.3Diluted shares (weighted), FY2022, twelve months to 2022-12-3129,271,777 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2025-03-31, accession 0000950170-25-047775.Report this figure34.1Diluted shares (weighted), FY2023, twelve months to 2023-12-3134,106,923 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure36.1Diluted shares (weighted), FY2024, twelve months to 2024-12-3136,105,671 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure52.2Diluted shares (weighted), FY2025, twelve months to 2025-12-3152,228,068 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-K filed 2026-03-24, accession 0001193125-26-121825.Report this figure

Shares outstanding: 72.48mShares outstanding, period not labelled, at 2026-07-3172,483,852 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335085.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.